Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-25-028767
Filing Date
2025-09-10
Accepted
2025-09-10 16:17:44
Documents
16
Effectiveness Date
2025-09-10

Document Format Files

Seq Description Document Type Size
1 FORM S-8 mbrx20250908_s8.htm S-8 69989
2 EXHIBIT 5 ex_859781.htm EX-5 8188
3 EXHIBIT 23.1 ex_859782.htm EX-23.1 2664
4 EXHIBIT 99.1 ex_859783.htm EX-99.1 84675
5 EXHIBIT 99.2 ex_859784.htm EX-99.2 89055
6 EXHIBIT FILING FEES ex_859785.htm   iXBRL EX-FILING FEES 16114
  Complete submission text file 0001437749-25-028767.txt   390112

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ex_859785_htm.xml XML 4711
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-290159 | Film No.: 251306085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)